Clinical trial
Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating…
NCT00064207 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00064207 |
|---|---|
| Title | Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer |
| Official title | Randomized Phase II/III Study Comparing Gemcitabine Followed by Gemcitabine Plus Concomitant Radiation (50.4 Gy) Versus Control After Curative Pancreaticoduodenectomy for Pancreatic Head Cancer |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Collaborators | Federation Francophone de Cancerologie Digestive |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | gemcitabine hydrochloride, adjuvant therapy, radiation therapy |
| Enrollment | 97 |
| Start date | May 1, 2003 |
| Primary completion | Jan 1, 2007 |
| First posted | Jul 9, 2003 |
| Last update posted | Sep 24, 2012 |
| Countries | Belgium, France, Germany, Israel, Netherlands, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: